France – Poches à sang – Fourniture d’équipements et de dispositifs médicaux intercept pour la préparation sécurisée et la viro-atténuation des produits sanguins labiles (PSL) par la technologie intercept et la réalisation de prestations associées.Les conditions administratives d’exécution des prestations sont définies dans le CCAP.Le descriptif technique et les conditions techn

AI summary

This tender concerns the supply of Intercept medical equipment and devices for secure preparation and virus attenuation of labile blood products through Intercept technology, along with associated services. The French Blood Establishment seeks a comprehensive solution for blood product pathogen reduction.

#blood products#medical devices#intercept technology#pathogen reduction#france#healthcare equipment#virus attenuation
Fit for

Medical device manufacturers or authorized distributors with proven expertise in blood product pathogen reduction technologies and compliance with EU medical device regulations.

Key requirements

Suppliers must provide Intercept technology equipment and devices certified for blood product processing, with technical documentation and associated support services as detailed in the technical specifications.

Frequently asked questions

  • What is this tender about?

    This tender concerns the supply of Intercept medical equipment and devices for secure preparation and virus attenuation of labile blood products through Intercept technology, along with associated services. The French Blood Establishment seeks a comprehensive solution for blood product pathogen reduction.

  • What are the requirements for suppliers?

    Suppliers must provide Intercept technology equipment and devices certified for blood product processing, with technical documentation and associated support services as detailed in the technical specifications.

  • What type of company should bid?

    Medical device manufacturers or authorized distributors with proven expertise in blood product pathogen reduction technologies and compliance with EU medical device regulations.

  • Who is the buyer?

    The buyer is Etablissement français du sang.

  • What is the estimated value?

    The estimated value is 80,100,000 EUR.

La présente consultation a pour objet la fourniture d’équipements et de dispositifs médicaux intercept pour la préparation sécurisée et la viro-atténuation des produits sanguins labiles (PSL) par la technologie intercept et la réalisation de prestations associées. Les conditions administratives d’exécution des prestations sont définies dans le CCAP. Le descriptif technique et les conditions techn

Buyer
Etablissement français du sang
Buyer ID: 42882285202140·Direction des achats, de l'immobilier et de la maintenance
20 avenue du Stade de France, 93210, Saint-denis
Body responsible for review procedures
Tribunal Administratif de Montreuil
Buyer ID: 1300068690015·Greffe du tribunal administratif de montreuil
7 rue Catherine PUIG, 93100, Montreuil
Other organization
CERUS EUROPE BV
Buyer ID: 493796940
STATIONSSTRAAT 79-D, 3811, AMERSFOORT

Computing match…

AI document analysis

We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.

Loading…